MEDI-493 humanized monoclonal antibody data

MEDI reported safety and tolerance data from a Phase I/II trial of MEDI-493 given by

Read the full 151 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE